Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

07 avr. 2015 09h15 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals to Present at 14th Annual Needham Healthcare Conference

VANCOUVER, British Columbia, April 7, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
16 mars 2015 16h25 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals Announces Year End 2014 Financial Results

VANCOUVER, British Columbia, March 16, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
10 mars 2015 09h20 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals to Announce Year End 2014 Financial Results and Host Conference Call on March 16, 2015

VANCOUVER, British Columbia, March 10, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
02 mars 2015 16h52 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals Completes Enrollment in the Phase 2 LEADERSHIP Trial of AQX-1125 in Bladder Pain Syndrome/Interstitial Cystitis

VANCOUVER, British Columbia, March 2, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
23 févr. 2015 09h10 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference

VANCOUVER, British Columbia, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
17 févr. 2015 09h15 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals Announces Changes to Board of Directors

VANCOUVER, British Columbia, Feb. 17, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
02 févr. 2015 09h10 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals Completes Enrollment in the Phase 2 FLAGSHIP Trial of AQX-1125 in Chronic Obstructive Pulmonary Disease Exacerbations

VANCOUVER, British Columbia, Feb. 2, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
29 janv. 2015 09h20 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals to Present at Upcoming Investor Conferences

VANCOUVER, British Columbia, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
30 déc. 2014 16h05 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals Initiates Patient Dosing in the Phase 2 Clinical Trial of AQX-1125 in Atopic Dermatitis

VANCOUVER, British Columbia, Dec. 30, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
09 déc. 2014 09h20 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals Announces Appointment of Mr. David C. Mitchell as Vice President, Global Regulatory Affairs & Quality Assurance

VANCOUVER, British Columbia, Dec. 9, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...

Page précédente